# Aquestive Therapeutics, Inc.

Type: Company (AQST)

Source: Finance Intelligence Brief — https://getfinancebrief.com/entity/aquestive-therapeutics-inc
Canonical HTML page: https://getfinancebrief.com/entity/aquestive-therapeutics-inc

## Recent coverage (1 stories)

### Pomerantz Law Firm Issues Litigation Deadlines for TCOM, AQST, and DRVN
2026-03-13 02:09:36 · Sentiment: Neutral · Impact: 5/10 · Sources: 3

Pomerantz Law Firm has issued urgent reminders for investors regarding class action lawsuits against Trip.com Group, Aquestive Therapeutics, and Driven Brands Holdings. These legal actions focus on alleged securities violations and material misrepresentations that resulted in significant shareholder losses.
Full story: https://getfinancebrief.com/story/pomerantz-law-firm-investor-alerts-tcom-aqst-drvn

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getfinancebrief.com/guides/methodology for the full editorial methodology.